Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Single Adductor Canal Block for ACL Reconstruction
NCT02584452Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Nov 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Subjective Postoperative Pain Scores and Quadriceps Strength. Started Nov 2015; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02584452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584452.